Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Addition to Triple Therapy for H. pylori Eradication
NCT03968302Phase 2Completed
- Sponsor
- Ziauddin University
- Start
- Jun 2018
- Primary completion
- May 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of bismuth subcitrate in Helicobacter pylori infection, sponsored by Ziauddin University. Started Jun 2018; status: completed.
02
Drugs
bismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03968302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03968302.